A Phase 3 Randomized Study of Intralesional Cemiplimab versus Primary Surgery in Participants with Early Stage Cutaneous Squamous Cell Carcinoma

Full Title

A Phase 3 Randomized Study of Intralesional Cemiplimab Versus Primary Surgery in Participants with Early Stage Cutaneous Squamous Cell Carcinoma (CSCC) (WCG IRB)

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Anthony Rossi’s office at 646-608-2342.

Protocol

25-348

Phase

Phase III (phase 3)

Investigator

Anthony Rossi

Co-Investigators

Kishwer S. Nehal

Diseases

Squamous Cell Carcinoma

Locations

Memorial Sloan Kettering Cancer Center

ClinicalTrials.gov ID

NCT06585410

ClinicalTrials.gov

Visit ClinicalTrials.gov for full clinical trial description